By expenditures
| Name | Title | Type |
|---|---|---|
| Mark Cherpak | Business Manager | Auditee |
| Chad Agnew | Shareholder | Auditee |
| Joel Martin | OWNER, MANAGING PARTNER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 343824 | 2024 | 2025-02-26 | Jmallc | $9.46M |
| 295428 | 2023 | 2024-03-16 | J Martin & Associates LLC | $4.54M |
| 56613 | 2022 | 2023-03-21 | J Martin & Associates LLC | $6.44M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 343824 | 2024 | 2025-02-26 | 1100922 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100921 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100920 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100919 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100918 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100917 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 1100916 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 1100915 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 1100914 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 1100913 | 2024-002 | Significant Deficiency | - | ABEGMN |
| 343824 | 2024 | 2025-02-26 | 1100912 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 1100911 | 2024-002 | Significant Deficiency | - | ABEGMN |
| 343824 | 2024 | 2025-02-26 | 524480 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524479 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524478 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524477 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524476 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524475 | 2024-002 | Significant Deficiency | - | ABFGLMN |
| 343824 | 2024 | 2025-02-26 | 524474 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 524473 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 524472 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 524471 | 2024-002 | Significant Deficiency | - | ABEGMN |
| 343824 | 2024 | 2025-02-26 | 524470 | 2024-002 | Significant Deficiency | - | ABEILN |
| 343824 | 2024 | 2025-02-26 | 524469 | 2024-002 | Significant Deficiency | - | ABEGMN |